Pixelgen

Healthcare

Pixelgen

Unleashing the Power of 3D Spatial Analysis with Pixelgen's MPX Technology

Average rated: 0.00/5 with 0 ratings

Favorited 0 times

Rate this tool

About Pixelgen

Pixelgen Technologies specializes in advancing the field of 3D spatial analysis of cell surface proteins, leveraging its proprietary Molecular Pixelation (MPX) technology. This innovative approach is aimed at enhancing the understanding of cell biology, disease mechanisms, and the development of new drugs and diagnostics. By enabling detailed examination of cell surface proteins and their spatial relationships within single cells, Pixelgen's technology provides insights that are unattainable through traditional analytical methods, which often lack the spatial resolution and multiplexing capabilities offered by MPX [1](https://www.pixelgen.com/)[2](https://www.pixelgen.com/products/). The core features of Pixelgen's MPX technology include 3D spatial single-cell proteomics, which facilitates high-resolution mapping of cell surface proteins. This technology supports deep phenotyping, particularly of immune cells, and allows for the simultaneous analysis of numerous proteins due to its high multiplexing capability using DNA-tagged monoclonal antibodies. Additionally, the high-throughput design enables the processing of a vast number of cells efficiently, supported by a simplified workflow that eliminates complex procedures commonly associated with similar technologies. MPX data is compatible with existing next-generation sequencing (NGS) workflows, complemented by the dedicated Pixelator software for data processing and analysis [2](https://www.pixelgen.com/products/)[4](https://www.pixelgen.one/products/index.html). Use cases for Pixelgen's technology include applications in immunology for understanding immune cell responses, cancer research for studying tumor growth and therapy responses, drug discovery for developing new medications with enhanced specificity, and the creation of diagnostic tools with improved accuracy. This breadth of applications underscores the technology's versatility and impact across various biomedical fields [1](https://www.pixelgen.com/)[2](https://www.pixelgen.com/products/). Pixelgen's key differentiators include its unparalleled 3D spatial resolution and high multiplexing capability, providing insights that are beyond the reach of many traditional single-cell technologies. The streamlined workflow further facilitates accessibility for a broad array of researchers, while integration with existing NGS workflows ensures seamless data processing and analysis [2](https://www.pixelgen.com/products/). Technical specifications for the Pixelgen Single Cell Spatial Proteomics Kit include a research focus on immunology, with digital spatial protein correlation NGS output. The input accommodates 500,000 cells, aliquot up to 1,000 cells for library preparation, and it features a protein panel of 84 targets. The data output capacity is up to 1,000 cells per reaction, offering a resolution of <100 nm/~200 nm and a protocol time of approximately two days [2](https://www.pixelgen.com/products/)[4](https://www.pixelgen.one/products/index.html). The technology is further enriched by integration with computational solutions developed in collaboration with BioLizard, which has optimized Pixelgen's computational pipelines, cloud infrastructure, and reporting tools [3](https://lizard.bio/knowledge-hub/software-engineering-molecular-pixelation). Recent developments include a December webinar focusing on the application of Molecular Pixelation in cancer research. This, coupled with ongoing collaboration with BioLizard, signifies Pixelgen's commitment to continuous innovation and refinement of its analytical tools and platforms [1](https://www.pixelgen.com/)[3](https://lizard.bio/knowledge-hub/software-engineering-molecular-pixelation).

Key Features

  • 3D spatial single-cell proteomics
  • High-resolution mapping of cell surface proteins
  • High multiplexing capability with DNA-tagged antibodies
  • Streamlined workflow compatible with NGS
  • Comprehensive data analysis with Pixelator software
  • Enhanced precision for drug discovery
  • Applications in immunology, cancer research, and diagnostics
  • Optimized computational solutions with BioLizard collaboration
  • Unparalleled spatial resolution
  • Seamless integration with existing workflows

Tags

3D spatial analysisMolecular Pixelationcell surface proteinscell biologydisease mechanismsdrug developmentdiagnostic development3D spatial resolutionmultiplexingsingle-cell analysisimmunologycancer researchNGS workflowscomputational solutions

FAQs

What is Pixelgen's Molecular Pixelation (MPX) technology?
MPX is a cutting-edge technology for 3D spatial analysis of cell surface proteins, offering high resolution and multiplexing capabilities.
How does MPX technology benefit biomedical research?
It enables detailed study of protein spatial relationships in cells, improving insights in immunology and cancer research.
What makes Pixelgen's MPX technology unique?
Its high 3D spatial resolution and multiplexing capabilities, along with integration into NGS workflows, make it unique.
Can MPX technology be used in drug discovery?
Yes, it aids in developing drugs with enhanced specificity by providing detailed analysis of cell surface proteins.
Is the workflow of Pixelgen's MPX technology complex?
No, it features a streamlined workflow, eliminating many complexities found in similar technologies.
What applications can benefit from MPX technology?
Applications in immunology, cancer research, drug discovery, and diagnostics can greatly benefit.
How many proteins can be analyzed simultaneously with MPX?
MPX allows simultaneous analysis of numerous proteins through high multiplexing using DNA-tagged antibodies.
Does Pixelgen offer any software for data analysis?
Yes, Pixelgen provides Pixelator software for comprehensive data processing and analysis of MPX data.
How is MPX technology integrated with computational tools?
It's optimized by BioLizard, enhancing computational pipelines and cloud infrastructure for better reporting.
What recent developments have been made with Pixelgen's technology?
Recent webinars on cancer applications and continued BioLizard collaboration highlight ongoing advancements.